1. Aduhelm (Aducanumab) Approved for the Treatment of Alzheimer's Disease, 2021. The Antibody Society. https://www.antibodysociety.org/antibody-therapeutic/aduhelm-aducanumab-approved-for-the-treatment-of-alzheimers-disease/. (Accessed 22 June 2021).
2. An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19
3. Antibody therapeutics approved or in regulatory review in the EU or US, n.d. The Antibody Society. https://www.antibodysociety.org/resources/approved-antibodies/. (Accessed 19 August 2021).
4. Current state of monoclonal antibody therapy for allergic diseases;Chen;Engineering,2021
5. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19;Commissioner,2020